Trait
ALK fusion
ALK fusion status
ALK gene translocation status
ALK mutation
ALK rearrangement
ALK status
ALK translocation
AST/ALT
Ability to safely receive investigational and SOC regimens
Ability to swallow oral medication
Absence of identifiable primary tumor or nodal disease
Absolute neutrophil count
Actionable mutations
Active infection
Active infections
Active tuberculosis
Acute coronary syndrome
Acute disease
Additional malignancy
Adenocarcinoma or undifferentiated carcinoma histology
Adjuvant chemotherapy tolerance
Adjuvant/neoadjuvant therapy
Advanced refractory solid tumors
Age
Age 18-75 years
Age ≥18 years
Allogeneic transplant
Alpha-fetoprotein level
Amenability to consolidation immunotherapy
Anti-hepatitis B core antibody
Anticoagulant treatment
Anticoagulation treatment
Arterial thrombotic events
Autoimmune disease
Autoimmune disease or immune deficiency
Autoimmune diseases
Autoimmune disorder
Autoimmune disorders
Autoimmune/inflammatory disorders
Bevacizumab treatment continuity
Bilirubin
Bleeding disorders
Blood pressure control
Body weight
Brain MRI or CT prior to registration
Brain imaging
Brain metastases
CNS metastases
COPD with respiratory failure
CRT sequence
CT chest with IV contrast or PET/CT
CYP3A4 inhibitors/inducers
Carcinomatous meningitis
Cardiac aneurysms
Cardiac conditions
Cardiac disease
Cardiac disease history
Cardiac function
Cardiovascular disease
Centrally located primary tumor <2 cm from nodal disease (overlap risk)
Chemotherapy cycles
Chemotherapy timing
Child-Pugh classification
Chronic immunosuppression
Cisplatin-based chemotherapy
Coagulation disorders
Complete resection
Concurrent HBV/HCV
Concurrent anti-cancer therapy
Concurrent antineoplastic therapy
Concurrent clinical trials
Concurrent/prior malignancy
Consent compliance
Contraception
Contraception compliance
Contraceptive use
Contraceptive use compliance
Creatinine clearance
Creatinine clearance ≥25 mL/min (Cockcroft-Gault)
Curative intent eligibility (clinical appropriateness)
Denosumab use
Diabetes
Diagnosis
Disease progression
Disease progression after anti-PD-1/PD-L1
Disease progression after neoadjuvant/adjuvant/consolidation anti-PD-1/PD-L1
Disease progression status
Disease recurrence timing
Drug allergy history
Drug hypersensitivity
Drug intolerance
EBV infection
ECG abnormalities
ECOG PS
ECOG Performance Status
ECOG performance status
ECOG performance status 0-2
EGFR TKI treatment failure
EGFR mutation
EGFR mutation status
EGFR status
EGFR/ALK status
Echocardiogram findings
End-organ function
Epstein-Barr virus (EBV) infection
Expected survival
Extracapsular extension
Female contraception compliance
Female pregnancy status
Genetic informed consent
Germline sequencing
Grade 3 active infection
Grade ≥2 pneumonitis from prior CRT
Gross disease remaining
HBV infection
HBV status
HCC diagnosis
HCV infection
HCV status
HER2 status
HIV infection
HIV status
Hematologic function
Hematologic function amenable to chemo/radiation
Hematological function
Hemoglobin
Hemoglobin level
Hemoptysis history
Hepatic disorder
Hepatitis B surface antigen
Hepatitis status
Histology
Histology exclusion
Hypersensitivity
Hypersensitivity to carboplatin or nab-paclitaxel
Hypersensitivity to monoclonal antibodies
ILD
ILD/pneumonitis
INR
Identified primary tumor and at least one nodal metastasis
Idiopathic pulmonary fibrosis/pneumonitis
Imaging timing
Immune-mediated therapy
Immunocompromised state
Immunostimulatory agents
Immunosuppressive medication
Immunosuppressive therapy
Infection
Inflammatory bowel disease
Informed consent
Inoperability status
Interstitial lung disease
Interstitial lung disease/pneumonitis
Investigational study participation
Investigational therapy
Investigator discretion
Investigator judgment
Investigator judgment early termination risk
KEAP1 mutation
KRAS mutation
Kaposi sarcoma/MCD in HIV
Known EGFR/ALK/other driver mutation
Known PD-L1 result
Lab abnormalities
Left ventricular ejection fraction
Leptomeningeal carcinomatosis
Life expectancy
Life-threatening non-cancer illness
Live attenuated vaccination
Live vaccination
Live vaccine
Liver enzymes
Liver function
MDS/AML
MRD status
Maintenance therapy history
Major surgery
Malabsorption syndromes
Male contraception
Male contraception compliance
Measurable disease
Medical/psychiatric conditions
Metastatic disease
Metastatic or locally recurrent gastro-oesophageal cancer
Minimal pleural effusion eligibility
Mixed histology
Mixed tumor histology
Monoclonal antibody hypersensitivity
N2 node sampling
NSCLC histology
NSCLC histology/cytology confirmation
NSCLC resection status
NSCLC stage
Negative pregnancy test within 14 days
Neoadjuvant radiotherapy
Neoadjuvant/adjuvant therapy history
Neurological/psychiatric disorders
No EGFR mutation or ALK fusion
No evidence of Stage IV
No evidence of distant metastases (by FDG PET/CT)
Non-healing wounds
Non-malignant pleural effusion status
Non-squamous NSCLC histology
Nucleoside analog treatment
Organ and marrow function
Organ function
Organ transplant
Other active malignancy
Other driver oncogenes
Other malignancy
Other primary malignancy
PD-1/PD-L1 expression
PD-L1 biomarker
PD-L1 expression
PD-L1 status
PD-L1 status exclusion
PD-L1 testing
PD-L1 tissue
PET-CT timing
PET/CT staging
"Pathologically proven non-operable stage IIB or III, node positive NSCLC"
Performance status
Pericardial effusion
Platelet count
Platelets
Platinum allergy
Platinum doublet contraindication
Platinum doublet cycles
Platinum doublet progression
Platinum-based chemotherapy contraindication
Pleural fluid cytology if effusion visible on CT and x-ray
Pneumonitis
Pneumonitis history
Pneumonitis/ILD
Positive microscopic margins
Post-op chest CT
Post-op recurrence
Pre-op FDG-PET/CT
Pre-op chest CT/MRI
Pre-op imaging coverage
Pre-op mediastinal staging
Pre-surgical plasma sample
Pregnancy or unwillingness to discontinue nursing
Pregnancy status
Pregnancy test
Pregnancy/breastfeeding status
Pregnancy/lactation status
Previous malignancies
Primary immunodeficiency
Primary tumor site
Primary tumor size ≤7 cm
Prior NSCLC therapy
Prior PARP inhibitor
Prior PD-1/PD-L1 treatment
Prior Stage III therapy
Prior TKI/crizotinib treatment
Prior adjuvant therapy
Prior anti-PD-1/PD-L1
Prior anti-PD-1/PD-L1 therapy
Prior anti-TIGIT therapy
Prior anti-VEGF therapy
Prior anti-cancer therapy lines
Prior bevacizumab plus platinum doublet treatment
Prior checkpoint inhibitor
Prior checkpoint inhibitor use
Prior checkpoint therapy
Prior chemoradiation
Prior high-dose chemotherapy
Prior immune-mediated therapy
Prior immunotherapy
Prior lung radiation
Prior neoadjuvant therapy
Prior or concurrent malignancy not interfering with trial
Prior platinum-based therapy
Prior radiotherapy to the study cancer
Prior sorafenib treatment
Prior systemic therapy
Prior systemic therapy for current cancer
Prior systemic treatment
Prior systemic treatment history
Prior targeted therapy for sensitizing mutation
Prior therapy
Prior therapy lines
Prior thoracic radiotherapy
Prior trastuzumab treatment
Prior treatment
Progression during CRT
Proteinuria
Psychotropic drug or alcohol abuse
Pulmonary conditions
Pulmonary fibrosis/pneumonitis
Pulmonary function
Pulmonary interstitial fibrosis
RECIST 1.1 evaluable disease by CT scan
RECIST evaluable lesions
RECIST v1.1 measurable disease
ROS1 rearrangement
Radiation dose
Radiation therapy
Re-resection status
Recent biological response modifiers
Recent bleeding events
Recent drug therapy
Recent investigational treatment
Recent radiotherapy
Recent surgery
Recent systemic therapy
Recurrent or refractory NSCLC
Renal function
Resection type
Residency and ancestry
STK11 mutation
Second malignancy history
Second-line therapy refusal
Seizure disorder
Sensitizing EGFR mutation
Separate tumor nodules in same lobe
Serum albumin
Serum bilirubin
Serum creatinine
Serum total bilirubin
Severe cardiac disease
Severe infection
Severe infections
Sex
Small cell histology
Small cell lung cancer
Smoking status
Spinal cord compression
Stage
Stage IIIB upstaging
Staging system
Steroid use
Study compliance willingness
Surgery recovery
Surgical candidacy
Surgical candidate
Surgical eligibility
Surgical margins
Surgical resectability/inoperability/refusal
Systemic corticosteroids
Systemic disease
Systemic infection
TACE eligibility
TKI treatment
TNM staging IIIB/IIIC/IV
Target lesion
Thyroid function
Time from progression to randomization
Toxicity
Toxicity from prior therapy
Toxicity recovery
Treatment start feasibility
Tuberculosis
Tumor sample
Tumor tissue
Tumor tissue and blood samples
Tumor tissue provision
Tumor tissue sample
Uncontrolled illness
Uncontrolled intercurrent illness
Unresectable/metastatic disease
Vascular aneurysms
Venous thrombotic events
Viral hepatitis status
Viral load
WHO Performance Status
Wedge resection
Weight loss
Whole blood transfusion
Wound healing
actionable_driver_oncogenes
actionable_genomic_alterations
actionable_molecular_alterations
active_infection
active_second_malignancy
additional_malignancy
adhesive_allergy
adjuvant_chemotherapy
adjuvant_neoadjuvant_timing
adjuvant_progression_timing
adjuvant_radiotherapy
adjuvant_therapy
age
alk_mutation
alk_rearrangement
alkaline_phosphatase
allogeneic_transplant
anc
arrhythmia_history
ast_alt
autoimmune_disease
autoimmune_disorder
autoimmune_inflammatory_disorder
bilirubin
biosample_provision
blood_pressure
body_weight
bone_marrow_function
brain_metastases
cardiac_conditions
cardiac_history
cardiovascular_cerebrovascular_condition
cardiovascular_disease
cardiovascular_history
cardiovascular_impairment
cerebrovascular_accident
chemotherapy_recovery
chronic_steroid_use
clinical_study_participation
cns_lesions
cns_metastases
compliance
concurrent_anticancer_therapy
concurrent_experimental_therapy
concurrent_investigational_therapy
corneal_disease
creatinine_clearance
ct_scan
curative_intent_therapy
current_pulmonary_conditions
device_operation
diabetes
diagnosis
disease_burden
disease_progression
disease_response
dlco
docetaxel_contraindication
drug_allergy
drug_hypersensitivity
early_stage_relapse
ecog_ps
egfr_alk_braf_ros1_mutation
egfr_alk_mutation
egfr_alk_ros1
egfr_alk_ros1_testing
egfr_alk_status
egfr_mutation
egfr_ros1_alk
enrollment_timing
fdg_pet_ct
female_contraception
fistula
follow_up_accessibility
gi_abnormalities
gi_absorption_condition
gi_disease
hbv_hcv_infection
hematological_dysfunction
hemoptysis
hepatic_dysfunction
hepatitis_b_c
high_dose_steroid
histology
hiv_infection
hiv_status
hypertension
ibd_gi_perforation
ild_history
ild_pneumonitis
ild_pneumonitis_history
immunodeficiency
immunodeficiency_immunosuppression
immunodeficiency_transplant_immunosuppression
immunosuppressive_drugs
immunosuppressive_medication
immunotherapy_contraindication
immunotherapy_hypersensitivity
implantable_devices
infection_status
informed_consent
institutionalization
intercurrent_illness
interference_condition
interstitial_lung_disease
investigational_therapy
ip_hypersensitivity
kras_mutation
leptomeningeal_cns_disease
leptomeningeal_disease
life_expectancy
live_vaccine
live_virus_vaccination
lvef
major_surgery
major_surgery_recovery
male_contraception
mds_aml_history
measurable_disease
measurable_lesion
medical_psychiatric_risk
metastatic_progression_timing
minor_surgery
mixed_histology
molecular_alterations
molecular_status
mrd_eligibility
neo_adjuvant_chemotherapy
organ_function
other_actionable_alterations
other_malignancy
other_malignancy_history
palliative_radiotherapy
pd_l1_expression
pd_l1_status
pd_l1_tps
pembrolizumab_monotherapy
pericarditis_history
peripheral_neuropathy
persistent_disease
pet_mri_brain
physician_assigned_therapy
planned_surgery
platelet_count
platelets
platinum_cycles
pneumonitis
pneumonitis_ild
post_platinum_therapy
post_treatment_imaging
pregnancy_breastfeeding
pregnancy_intent
pregnancy_lactation
pregnancy_status
pregnancy_test
preop_imaging
preop_radiotherapy
primary_immunodeficiency
prior_adjuvant_pd_l1
prior_adjuvant_therapy
prior_brain_mets
prior_checkpoint_inhibitor
prior_checkpoint_therapy
prior_crt
prior_definitive_therapy
prior_immune_related_ae
prior_immune_therapy
prior_induction_therapy
prior_io_agent
prior_io_rtki_therapy
prior_io_therapy
prior_kras_g12c_inhibitor
prior_lung_radiotherapy
prior_mmae_ib6_therapy
prior_parp_inhibitor
prior_pd1_pdl1_therapy
prior_pneumonitis
prior_radiotherapy
prior_systemic_therapy
prior_systemic_treatment
prior_topoisomerase_adc
prior_toxicity
prior_transplant
prior_transplantation
progression_during_crt
psychiatric_condition
pulmonary_compromise
pulmonary_disease
qtcf_interval
questionnaire_completion
radiation_dose
radiation_technique
recent_antitumor_therapy
recent_colony_stimulating_factor
recent_mri_brain
recent_pet
recent_radiotherapy
recent_steroids
recovery_from_prior_therapy
renal_dysfunction
resection_types
residual_disease_site
ros1_rearrangement
second_malignancy
second_screen_imaging
sequential_crt
sex
small_cell_sarcomatoid
smoking_status
spinal_cord_compression
stable_brain_mets
stage
surgical_resection
surveillance_consent
surveillance_start_timing
swallowing_ability
synchronous_tumors
systemic_therapy_timing
third_space_fluid_retention
tissue_provision
treatment_start
tuberculosis
tumor_biopsy
tumor_cavitation_vessel_invasion
tumor_size_number
tumor_specimen
tumor_tissue
unapproved_surgical_procedures
unresectable_nsclc
unresectable_status
washout_period
wedge_resection
who_ps
whole_blood_transfusion
wound_healing
